NYU LANGONE HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
TeleRehabilitation Following Arthroscopic Rotator Cuff Repair
Not Applicable
Completed
- Conditions
- Rotator Cuff Injuries
- Interventions
- Other: Telerehabilitation TherapyOther: In-person Rehabilitation Therapy
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 32
- Registration Number
- NCT04541953
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
Not Applicable
Completed
- Conditions
- ACL
- Interventions
- Device: DBMDevice: Calcium phosphate cementOther: Autologous bone graft
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 150
- Registration Number
- NCT04533880
- Locations
- 🇺🇸
NYU Langone Orthopedic Hospital, New York, New York, United States
COVID-19 Survivorship Registry
Recruiting
- Conditions
- Covid19
- Interventions
- Other: Questionnaires
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 1200
- Registration Number
- NCT04527315
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Parenteral Nutrition Light Protection and Premature Outcomes
Not Applicable
Completed
- Conditions
- Premature Birth
- Interventions
- Other: Full parenteral nutrition light protection of the bag, tubing and lipids
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 36
- Registration Number
- NCT04525872
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery
Phase 4
Completed
- Conditions
- Pain, PostoperativeSpine Injuries and DisordersNarcotic Use
- Interventions
- Drug: Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 44
- Registration Number
- NCT04522206
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.
Early Phase 1
Completed
- Conditions
- Chronic Kidney Diseases
- Interventions
- Other: Integrated ambulatory palliative and nephrology careOther: Standard nephrology care
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 45
- Registration Number
- NCT04520984
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
Completed
- Conditions
- Covid19Acute Respiratory Distress SyndromeBacterial SepsisBacterial Infections
- Interventions
- Device: BVA-100Device: Transpulmonary Thermodilution (TPTD)Device: Sublingual Microcirculation
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 39
- Registration Number
- NCT04517695
- Locations
- 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
🇺🇸NYU Langone Health, New York, New York, United States
🇺🇸Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States
Integrating the Quit and Stay Quit Monday Model Into Smoking Cessation Services for Smokers With Mental Health Conditions
Not Applicable
Completed
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Quit and Stay Quit Monday Model
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 70
- Registration Number
- NCT04512248
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Evolocumab In Advanced Chronic Kidney Disease Trial
Phase 4
Withdrawn
- Conditions
- Chronic Kidney DiseasesHigh Cholesterol
- Interventions
- Other: Placebo
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2022-07-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT04510844
- Locations
- 🇺🇸
NYU Langone Nephrology Associates - Long Island, Mineola, New York, United States
🇺🇸NYU Langone Health, New York, New York, United States
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
Not Applicable
Completed
- Conditions
- Hematologic Malignancy
- Interventions
- Radiation: Linac Based VMAT TBI
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 35
- Registration Number
- NCT04509765
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath